Home Gilead: Another Competitor Bites The Dust
 

Keywords :   


Gilead: Another Competitor Bites The Dust

2014-11-12 04:58:35| Biotech - Topix.net

Despite a very successful 2014 that included an almost quadrupling of earnings, investors remain overly pessimistic on the prospects of Gilead Sciences. The stock is cheap, competitors continue to fail to make inroads into its core hepatitis C franchise and sales there are just getting started and should continue to beat expectations.

Tags: dust bites competitor gilead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »